Press release
Increasing Applications of Beta-Glucan in Food & Beverage and Pharmaceuticals Driving the Market Growth
The Beta-Glucan Market size is estimated to account for a value of USD 403.8 million in 2020 and is projected to grow at a CAGR 7.6% from 2020, to reach a value of USD 628.3 million by 2026. Factors such as the increasing research on beta-glucan, clubbed with its functional benefits has been the key areas that has supported the market growth of beta-glucan. Moreover, there is an increase in the application of beta-glucan in fast-moving industries, such as food & beverage and pharmaceuticals due to its health-promoting and prebiotic properties that has also helped in the growing demand for the market. It is also used across other application areas such as nutraceuticals, cosmetics, personal care, and animal feed.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5191796
By category the soluble segment is expected to hold a higher share as compared to the insoluble segment
Soluble dietary fibers also reduce the total plasma cholesterol and lower the glycemic index of food providing numerous health benefits. Insoluble beta-glucan is found in larger amounts in cereal, such as brown rice. Wholemeal flour and bread, wholegrain breakfast cereals, brown rice, corn bran, and wholemeal pasta are all good sources. This type of fibrous beta-glucan is vital for a healthy digestive system further leading to the segment holding a significant share in the overall market for beta-glucan.
The yeast segment as a source is expected to hold one of the largest share in the beta-glucan market, in terms of value, in 2020
Baker’s yeast grows aerobically and is dependent on sugar molasses, whereas brewer’s yeast is not. Baker’s yeast is estimated on the basis of consumption of baker’s product while brewer’s yeast depends on alcohol products. The immune-modulating abilities of the final product together with supportive research studies for the immune-modulating properties of baker’s yeast has driven the demand for yeast beta-glucan globally.
By application pharmaceutical and food & beverage will be the key areas to drive the demand for beta-glucan, in terms of value, in 2020
Pharmaceutical products come in the form of capsules, liquid, powder, or tablets and are taken to balance the deficiencies of ingredients in diets and for curing problems, such as obesity, blood pressure, and diabetes. These products have been extensively studied for their immunological and pharmacological effects. Immunologically active, homogeneous, non-aggregated, and micro-particulate beta-glucan is prepared from saccharomyces cerevisiae which has resulted in growing applications across the industry. Moreover, the rising sedentary lifestyle and increased consumption of calorie-rich food, have caused numerous health problems, such as obesity, high blood pressure, high cholesterol, and heart attack. The intake of beta-glucan has helped in reducing the risk of these health problems with its health-promoting properties further driving the beta glucan applications
North America is projected to dominate the majority market share, in the global beta-glucan market, in terms of value, in 2020
The North American beta-glucan market is led by its broad applications in various products along with their health benefits. The key market players in the North American beta-glucan market include Cargill (U.S.), Millipore Sigma (U.S.), and Lesaffre (U.S.). Technological advancements have made beta-glucan available for a wide range of applications in the food & beverage sector in the form of thickening agents, fat substitutes, dietary fiber, and hypocholesterolemia agents; these are likely to drive the growth in the region.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=5191796
In addition, the US has a large market for bakery, confectionery, convenience food, and packaged food products, and hence, it accounts for a major share in the market. Consumers in the US are calorie-conscious, due to which low-calorie and low-fat food products are popular in the country. The increase in the prevalence of obesity and cardiac diseases has led to a surge in demand for natural and low-calorie ingredient-based food products among consumers. According to the Centre for Disease Control & Prevention (CDC) and from the data provided by National Health and Nutrition Examination Survey, in the US, the prevalence of obesity was 39.8% and affected nearly 93.3 million of the adult population between 2015 and 2016.
Leading companies operating in the beta-glucan market are Cargill Inc (US), Tate & Lyle Plc (UK), Kerry Group Plc (Ireland), Koninklijke DSM N.V. (Netherlands), Frutarom (Israel), Garuda International Inc (US), Ohly GmbH (Germany), Milliporesigma (US), Super Beta Glucan (US), Lesaffre Human Care (France), Kemin Industries (US), Angel Yeast Co Ltd (China), Biotec BetaGlucans AS (Norway), AIT Ingredients (France), Biorigin Zilor (Brazil), Ceapro Inc (Canada), Specialty Biotech Co Ltd (Thailand), and Alltech Life Sciences (US) among others.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Applications of Beta-Glucan in Food & Beverage and Pharmaceuticals Driving the Market Growth here
News-ID: 2261502 • Views: …
More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624
These fertilizers are prized for their ability…

Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,…

Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%.
Download PDF Brochure:…

Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…